JP2015524788A5 - - Google Patents

Download PDF

Info

Publication number
JP2015524788A5
JP2015524788A5 JP2015501980A JP2015501980A JP2015524788A5 JP 2015524788 A5 JP2015524788 A5 JP 2015524788A5 JP 2015501980 A JP2015501980 A JP 2015501980A JP 2015501980 A JP2015501980 A JP 2015501980A JP 2015524788 A5 JP2015524788 A5 JP 2015524788A5
Authority
JP
Japan
Prior art keywords
peptide
amino acid
cells
apc
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015501980A
Other languages
English (en)
Japanese (ja)
Other versions
JP6259983B2 (ja
JP2015524788A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2013/004248 external-priority patent/WO2014010231A1/en
Publication of JP2015524788A publication Critical patent/JP2015524788A/ja
Publication of JP2015524788A5 publication Critical patent/JP2015524788A5/ja
Application granted granted Critical
Publication of JP6259983B2 publication Critical patent/JP6259983B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015501980A 2012-07-10 2013-07-09 Th1細胞のKIF20Aエピトープペプチドおよびこれを含有するワクチン Expired - Fee Related JP6259983B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261669999P 2012-07-10 2012-07-10
US61/669,999 2012-07-10
PCT/JP2013/004248 WO2014010231A1 (en) 2012-07-10 2013-07-09 Kif20a epitope peptides for th1 cells and vaccines containing the same

Publications (3)

Publication Number Publication Date
JP2015524788A JP2015524788A (ja) 2015-08-27
JP2015524788A5 true JP2015524788A5 (enExample) 2016-06-02
JP6259983B2 JP6259983B2 (ja) 2018-01-17

Family

ID=49915712

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015501980A Expired - Fee Related JP6259983B2 (ja) 2012-07-10 2013-07-09 Th1細胞のKIF20Aエピトープペプチドおよびこれを含有するワクチン

Country Status (5)

Country Link
US (3) US9561265B2 (enExample)
EP (1) EP2872530A4 (enExample)
JP (1) JP6259983B2 (enExample)
TW (4) TWI659043B (enExample)
WO (1) WO2014010231A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015164826A2 (en) * 2014-04-24 2015-10-29 Rhode Island Hospital ASPARTATE-β-HYDROXYLASE INDUCES EPITOPE-SPECIFIC T CELL RESPONSES IN TUMORS
GB201522667D0 (en) * 2015-12-22 2016-02-03 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
HRP20210698T1 (hr) 2015-12-22 2021-09-17 Immatics Biotechnologies Gmbh Peptidi i kombinacija peptida za uporabu u imunoterapiji protiv karcinoma dojke i drugih karcinoma
WO2018092755A1 (en) * 2016-11-18 2018-05-24 Oncotherapy Science, Inc. Mphosph1 epitope peptides for th1 cells and vaccines containing the same
JP2019535270A (ja) * 2016-11-18 2019-12-12 オンコセラピー・サイエンス株式会社 Th1細胞のためのDEPDC1エピトープペプチドおよびこれを含有するワクチン
US11564980B2 (en) 2018-04-23 2023-01-31 Nantcell, Inc. Tumor treatment method with an individualized peptide vaccine
TWI816603B (zh) * 2018-04-23 2023-09-21 美商南特細胞公司 新抗原表位疫苗及免疫刺激組合物及方法

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4722848A (en) 1982-12-08 1988-02-02 Health Research, Incorporated Method for immunizing animals with synthetically modified vaccinia virus
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US6150584A (en) 1990-01-12 2000-11-21 Abgenix, Inc. Human antibodies derived from immunized xenomice
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
WO1992003918A1 (en) 1990-08-29 1992-03-19 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5804566A (en) 1993-08-26 1998-09-08 The Regents Of The University Of California Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides
US5679647A (en) 1993-08-26 1997-10-21 The Regents Of The University Of California Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides
US5739118A (en) 1994-04-01 1998-04-14 Apollon, Inc. Compositions and methods for delivery of genetic material
US5736524A (en) 1994-11-14 1998-04-07 Merck & Co.,. Inc. Polynucleotide tuberculosis vaccine
US5922687A (en) 1995-05-04 1999-07-13 Board Of Trustees Of The Leland Stanford Junior University Intracellular delivery of nucleic acids using pressure
US5853719A (en) 1996-04-30 1998-12-29 Duke University Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
US6294378B1 (en) 1996-07-26 2001-09-25 Sloan-Kettering Institute For Cancer Research Method and reagents for genetic immunization
AU749544B2 (en) 1998-06-25 2002-06-27 Dainippon Sumitomo Pharma Co., Ltd. Tumor antigen peptides originating in cyclophilin B
US7504490B1 (en) * 1998-10-16 2009-03-17 Oscient Pharmaceuticals Corporation Nucleic acid and amino acid sequences relating to Apergillus fumigatus for diagnostics and therapeutics
US6395527B1 (en) * 2000-08-17 2002-05-28 Cytokinetics, Inc. Motor proteins and methods for their use
WO2002101075A2 (en) * 2001-06-13 2002-12-19 Millennium Pharmaceuticals, Inc. Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
US20040142325A1 (en) * 2001-09-14 2004-07-22 Liat Mintz Methods and systems for annotating biomolecular sequences
US20060143729A1 (en) * 2004-06-30 2006-06-29 Ceres, Inc. Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
JP5109131B2 (ja) 2005-02-10 2012-12-26 オンコセラピー・サイエンス株式会社 膀胱癌を診断する方法
EP2305811A1 (en) 2005-07-27 2011-04-06 Oncotherapy Science, Inc. Method of diagnosing smal cell lung cancer
WO2007027866A2 (en) * 2005-08-30 2007-03-08 Monsanto Technology Llc Transgenic plants with enhanced agronomic traits
AU2007218045B2 (en) * 2006-02-20 2011-11-10 Phylogica Limited Method of constructing and screening libraries of peptide structures
EP2052088A2 (en) * 2006-08-02 2009-04-29 Genizon Biosciences Genemap of the human genes associated with psoriasis
WO2008102906A1 (en) 2007-02-20 2008-08-28 Oncotherapy Science, Inc. Hspc-hrpc transition genes
TWI615403B (zh) 2007-02-21 2018-02-21 腫瘤療法 科學股份有限公司 表現腫瘤相關抗原之癌症的胜肽疫苗
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
US8883966B2 (en) 2008-10-22 2014-11-11 Oncotherapy Science, Inc. RAB6KIFL/KIF20A epitope peptide and vaccines containing the same
US10706955B2 (en) * 2010-03-23 2020-07-07 Iogenetics, Llc Bioinformatic processes for determination of peptide binding

Similar Documents

Publication Publication Date Title
JP2015524788A5 (enExample)
JP2015529629A5 (enExample)
IL302102A (en) shared neoantigens
JP2014523406A5 (enExample)
JP2013521789A5 (enExample)
JP2017525336A5 (enExample)
JP2013511958A5 (enExample)
HRP20141233T1 (hr) PEPTIDNA CJEPIVA DOBIVENA IZ EphA4
JP2018536383A5 (enExample)
JP2019510465A5 (enExample)
JP2018511321A5 (enExample)
JP2016511221A5 (enExample)
JP2016525498A5 (enExample)
Welten et al. Memory CD 8 T cell inflation vs tissue‐resident memory T cells: Same patrollers, same controllers?
HRP20192262T1 (hr) Nova imunoterapija protiv nekoliko tumora, kao što su rak pluća, uključujući mikrocelularni karcinom pluća (nsclc)
PE20181897A1 (es) Inmunoterapia contra el melanoma y otros tipos de cancer
JP2012517799A5 (enExample)
JP2014519311A5 (enExample)
JP2019508044A5 (enExample)
RU2012127358A (ru) Олигопептиды imp-3 и содержащие их вакцины
RU2015143164A (ru) Пептиды kntc2 и содержащие их вакцины
JP2015524652A5 (enExample)
JP2012102105A5 (enExample)
JP2013517764A5 (enExample)
JP2013523084A5 (enExample)